But weren't those studies conducted with maravoric, and that drug completely inhibits CCR5? I question this because like what you posted there, HSV² was seen to spread more and more outbreaks due to less CCR5 . But if Leronlimab doesnt inhibit the CCR5 response as other completely do, maybe this would be different? Any thoughts on this?